Medical Condition News

RSS

How 30 kidneys linked 60 lives

The New York Times examines a lengthy kidney transplant chain and explores how the current system continues to hamper transplantation efforts.

22 Feb 2012

AAN to honor Tokyo neurologist with Potamkin Prize for AD research

The American Academy of Neurology is awarding its 2012 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Takeshi Iwatsubo, MD, PhD, with the University of Tokyo School of Medicine. Iwatsubo will receive the award during the Academy's 64th Annual Meeting, April 21-28, 2012, in New Orleans.

22 Feb 2012

Simple blood test may provide early detection of cancer

A simple blood test is being developed by researchers at Ben-Gurion University of the Negev (BGU) and Soroka University Medical Center in Beer-Sheva, Israel that may provide early detection of many types of cancer.

22 Feb 2012

Childhood Obesity celebrates second anniversary of Let's Move! initiative

Faith-based advocacy has been cited as a valuable tool in combating childhood obesity, but evidence is needed to support this assertion and to define how the link between advocacy and policy can contribute to promoting permanent lifestyle changes. This article is part of a special issue of the journal Childhood Obesity celebrating the second anniversary of First Lady Michelle Obama's Let's Move! initiative.

22 Feb 2012

Study reveals how mutation shuts down DJ-1 protein's neuroprotective abilities

Purdue University researchers revealed how a mutation in a protein shuts down a protective function needed to prevent the death of neurons in Parkinson's disease, possibly opening the door to new drug strategies to treat the disorder.

22 Feb 2012

Combination of key guideline-recommended heart failure therapies improve survival odds

A UCLA-led study has found that a combination of several key guideline-recommended therapies for heart failure treatment resulted in an improvement of up to 90 percent in the odds of survival over two years.

22 Feb 2012

FDA approves APP's preservative-free Methotrexate Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.

22 Feb 2012

New injectable hydrogel can treat tissue damage from heart attack

University of California, San Diego researchers have developed a new injectable hydrogel that could be an effective and safe treatment for tissue damage caused by heart attacks.

22 Feb 2012

Researchers discover mechanism of thermostat protein

Johns Hopkins and National Taiwan University researchers have discovered more details about how an energy sensing "thermostat" protein determines whether cells will store or use their energy reserves.

22 Feb 2012

ALS Association, AAN to honor KCL neurologist with Essey Award

The American Academy of Neurology and the ALS Association are awarding the 2012 Sheila Essey Award: An Award for ALS Research to Christopher Shaw, MBChB, MD, FRACP, with the Institute of Psychiatry at King's College London. Shaw will receive the award during the Academy's 64th Annual Meeting, April 21-28, 2012, in New Orleans.

22 Feb 2012

Foreign-born Hispanics in the U.S. might have lower risk of stroke

New research finds foreign-born Hispanics now living in the United States appear to be less likely to have a stroke compared to non-Hispanic white people.

22 Feb 2012

Link between brain dominance and laterality of cell phone use

If you're a left brain thinker, chances are you use your right hand to hold your cell phone up to your right ear, according to a new study from Henry Ford Hospital in Detroit.

22 Feb 2012

First study to gauge college students' willingness to donate to a genetic biobank

A majority of college students is receptive to donating blood or other genetic material for scientific research, according to a new study from Southern Methodist University, Dallas.

22 Feb 2012

VTT participates in two new EU projects that focus on type 2 diabetes

VTT is participating in two new European projects focusing on type 2 diabetes. The projects aim at identifying new therapeutic choices and strategies for preventing the disease. Focus is on obtaining information on cellular dysfunction in diabetes and the effects of changes in lifestyle. The goal includes planning individual lifestyle instructions for people at high risk of diabetes and exploiting the results in a major European health insurance system.

22 Feb 2012

AAN, National MS Society to honor Cleveland Clinic researcher with John Dystel Prize

The American Academy of Neurology and the National Multiple Sclerosis Society are awarding the 2012 John Dystel Prize for MS Research to Richard M. Ransohoff, MD, with the Cleveland Clinic. Ransohoff, a member of the American Academy of Neurology and Associate Editor of Neurology, the Academy's medical journal, will receive the award at the Academy's 64th Annual Meeting in New Orleans, April 21-28, 2012.

22 Feb 2012

Referees' stress tolerance does not depend on specific physical condition

All referees feel stress on match days. However, contrary to what you might believe, a joint study by the Catholic University of Brasilia, A Coru-a University and James Cook University in Australia state that the level of stress is not linked to the physical condition of these referees, but to their nervous system. The researchers measured the activity of Spanish football referees on a normal day and on a match day.

22 Feb 2012

BioLineRx BL-7010 may reduce gluten toxicity in patients with celiac disease

BioLineRx, a biopharmaceutical development company, announced the publication of pre-clinical results demonstrating that BL-7010, an orally available treatment for celiac disease, reduces gluten toxicity (the negative effect of gluten on the patient's body).

22 Feb 2012

New chemical compound to treat brain damage from stroke

Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke. The compound binds 1,000 times more effectively to the target protein in the brain than the potential drug currently being tested on stroke victims.

22 Feb 2012

Mitochondria may be promising new target for cancer treatment

Mitochondria, tiny structures within each cell that regulate metabolism and energy use, may be a promising new target for cancer therapy, according to a new study. Manipulation of two biochemical signals that regulate the numbers of mitochondria in cells could shrink human lung cancers transplanted into mice, a team of Chicago researchers report in the journal FASEB.

22 Feb 2012

Insulin production may persist for decades after onset of type 1 diabetes

Massachusetts General Hospital (MGH) research has found that insulin production may persist for decades after the onset of type 1 diabetes. Beta cell functioning also appears to be preserved in some patients years after apparent loss of pancreatic function. The study results appear in the March issue of Diabetes Care.

22 Feb 2012